Home / Stocks / Qms Medical Allied S Ltd
QMSMEDI Updated about 10 hours ago

Qms Medical Allied S Ltd Share Price

NSE closing price and which mutual funds hold this stock

Daily NSE closing prices — this stock isn't in the live-tracked universe yet.

NSE Close — 19 Nov 2026

₹170.99

Change

+0.98 (0.58%)

Open

₹170.2

Prev. Close

₹170.01

Day High

₹172.9

Day Low

₹170.2

Volume Analysis

Traded

12,323

End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.

Strengths, Weaknesses, Opportunities & Threats

Strengths (0)

No signal for this stock

Weaknesses (1)

  • •Promoter holding is falling

Opportunities (0)

No signal for this stock

Threats (0)

No signal for this stock

Rule-based signals from the fundamentals below — not investment advice.

Pivot Levels

Type R3 R2 R1 Pivot S1 S2 S3
Classic ₹175.22 ₹174.06 ₹172.52 ₹171.36 ₹169.82 ₹168.66 ₹167.12
Fibonacci ₹174.06 ₹173.03 ₹172.39 ₹171.36 ₹170.33 ₹169.69 ₹168.66
Camarilla ₹171.73 ₹171.49 ₹171.24 ₹171.36 ₹170.74 ₹170.5 ₹170.25

Support/resistance levels for today, calculated from the previous trading day's high/low/close.

Absolute Returns

YTD

—

1 Week

-1.34%

1 Month

-0.24%

3 Months

+15.23%

6 Months

—

1 Year

—

2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.

Stock Vitals

Computed from the latest available annual financials.

Graham Number

₹79.72

Current price is above the Graham Number — Benjamin Graham's estimate of fair value based on earnings and book value.

DuPont ROE Breakdown

11.79%

Net margin 7.1% × asset turnover 0.81x × equity multiplier 2.05x

Company Overview

Sector

Healthcare

Market Cap

₹336 Cr

P/E (TTM)

31.3

ROE

10.4%

Book Value

₹53.9

Face Value

₹10.0

Source: Screener.in (Consolidated figures) — data as of 19 Nov 2026. Not investment advice.

TopFund Analysis

Qms Medical Allied S Ltd lands in the middle of the pack on TopFund's composite fundamentals check within the Healthcare sector, at 55/100. The strongest factor is Risk & Volatility (81/100), while Liquidity (0/100) is the weakest area to weigh before deciding. Notably: Promoter holding is falling.

TopFund Score — Fundamentals Quality

55/100 — Average

Data confidence: 75/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.

As of 19 Nov 2026 · How we calculate this →

Financial Strength

76

Valuation

43

Cash Flow

63

Corporate Governance

43

Momentum

71

Institutional Ownership

41

Business Quality

57

Risk & Volatility

81

Liquidity

0

From Screener.in

  • +Company has been maintaining a healthy dividend payout of 56.4%
  • −Stock is trading at 3.23 times its book value
  • −Company has a low return on equity of 12.0% over last 3 years.
  • −Promoter holding has decreased over last 3 years: -5.56%

Not investment advice — an automated read of public fundamentals data, for research context only.

Corporate Actions

Q2 and H1 FY27 earnings conference call scheduled for 17 November 2026 at 11:30 AM IST.

Regulation 74(5) certificate confirms entire shareholding in demat form for quarter ended September 30, 2026.

QMS Medical Allied Services’ 9th AGM resolutions passed; final dividend of Re.0.50 per share approved.

Source: BSE regulatory filings, via Screener.in.

Quarterly Results

Last several quarters

  Dec 2023 Mar 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Sales + 35 32 37 44 45 47 45 37 44 57
Expenses + 30 28 30 37 38 40 38 31 39 49
Operating Profit 5 4 7 7 6 7 7 7 6 8
OPM % 13.73% 12.23% 19.46% 15.82% 14.29% 14.06% 15.48% 18.12% 13.33% 14.61%
Other Income + 0 0 0 0 1 0 0 0 0 0
Interest 1 1 1 1 1 1 1 2 2 2
Depreciation 1 1 1 1 1 1 1 1 1 1
Profit before tax 3 2 6 5 5 4 5 4 3 6
Tax % 25.76% 29.68% 25.27% 30.24% 23.24% 29.62% 26.24% 25.7% 29.21% 28.65%
Net Profit + 2 2 4 3 4 3 4 3 2 4
EPS in Rs 1 1 2 2 2 2 2 1 1 2
Raw PDF — — — — — — — — — —
YoY Sales growth — — — 24 38 — 20 -15 0 22

Source: Screener.in — figures in ₹ Crores unless marked %.

Profit & Loss (Yearly)

  Mar 2024 Mar 2025 Mar 2026 TTM
Sales + 122 156 173 183
Expenses + 104 130 147 155
Operating Profit 18 25 26 28
OPM % 15.0% 16.0% 15.0% 15.0%
Other Income + 0 2 1 1
Interest 3 5 7 7
Depreciation 3 4 4 5
Profit before tax 12 19 16 17
Tax % 26.0% 27.0% 27.0% —
Net Profit + 9 14 12 13
EPS in Rs 5 7 5 6
Dividend Payout % 0.0% 74.0% 95.0% —
Sales growth — 28 11 6

Source: Screener.in — figures in ₹ Crores unless marked %.

Balance Sheet

  Mar 2024 Mar 2025 Mar 2026
Reserves 61 72 85
Borrowings + 35 60 74
Other Liabilities + 22 40 34
Total Liabilities 135 190 213
Fixed Assets + 24 52 55
CWIP 2 3 3
Investments 2 3 5
Other Assets + 108 131 150
Total Assets 135 190 213
Equity Capital 18 18 19

Source: Screener.in — figures in ₹ Crores unless marked %.

Cash Flow

  Mar 2024 Mar 2025 Mar 2026
Cash from Operating Activity + 1 19 19
Cash from Investing Activity + -3 -45 -20
Cash from Financing Activity + 0 27 1
Net Cash Flow -1 1 0
Free Cash Flow 1 19 19
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit 26 97 93

Source: Screener.in — figures in ₹ Crores unless marked %.

Shareholding Pattern

Quarter-by-quarter — Promoters, FII, DII & public holding trend

Promoter holding: 73.67% → 68.11%
  Dec 2022 Mar 2023 Sep 2023 Mar 2024 Sep 2024 Mar 2025 Jun 2025 Sep 2025 Mar 2026 Jun 2026 Sep 2026
Public 25.62% 25.12% 25.32% 26.33% 26.33% 26.33% 26.33% 30.28% 30.3% 30.3% 30.17%
Promoters 73.67% 73.67% 73.67% 73.67% 73.67% 73.67% 73.67% 68.11% 68.11% 68.11% 68.11%
FII 0.71% 1.21% 1.02% 0.01% 0.01% 0.01% 0.01% 0.01% 0.0% 0.0% 0.41%
DII 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 1.6% 1.59% 1.59% 1.3%

Source: Screener.in — quarterly shareholding disclosures.

Peers Comparison

Healthcare — ranked by market cap

Company Market Cap (Cr) P/E P/B ROE
Qms Medical Allied S Ltd (this stock) 336 31.3 3.23 10.4%
Lyka Labs Ltd. 328 — 3.39 -10.2%
Ambalal Sarabhai Ent L 304 19.6 1.86 12.4%
Nureca Limited 293 61.4 1.56 1.12%
Medicamen Biotech Limited 407 35.2 1.39 3.95%
Brooks Lab Limited 203 58.7 1.08 22.0%
Bilcare Ltd. 202 5.55 1.13 1.39%

Which Mutual Funds Hold Qms Medical Allied S Ltd?

Frequently Asked Questions about Qms Medical Allied S Ltd

Community Sentiment

What are other investors saying about Qms Medical Allied S Ltd?

No votes yet — be the first to share your view.

Sign in to vote

Discussion

User-generated content — not investment advice, and not verified or endorsed by TopFund.

Sign in to join the discussion

No comments yet — start the discussion.